Journal of Clinical Oncology on Twitter: "Trastuzumab and docetaxel in HER2-positive salivary duct carcinoma https://t.co/NOmMm07JqO https://t.co/2th6T5QlHd" / Twitter
Read in JCO:... - American Society of Clinical Oncology | Facebook
Top 50 Most-Cited Journal of Clinical Oncology Articles From 2018 -
Archives | Oncology Journal | Open Access Cancer Research
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges | Nature Reviews Clinical Oncology
Access Best of JCO 2018 ESMO Edition | Journal of Clinical Oncology
Educating undergraduate medical students about oncology. a literature…
2018 State of Cancer Care in America – The Cancer History Project
Risk-Imaging Mismatch: Why Is There a Disconnect? | Journal of Clinical Oncology
Systemic Management of iCCA: Role of Molecular Therapies - ppt download
PDF) Study protocol for J-SUPPORT 1604 (J-FORCE): A randomized, double blind, placebo-controlled Phase III study evaluating olanzapine (5 mg) plus standard triple antiemetic therapy for prevention of chemotherapy induced nausea and vomiting
Harborside • The Nexus of Knowledge
Circulating Tumor DNA–Defined Minimal Residual Disease in Solid Tumors: Opportunities to Accelerate the Development of Adjuvant Therapies | Journal of Clinical Oncology
ASCO 2018 Abstracts Released — All 650 Pages Worth! - Cancer Health
PDF) Randomized phase III trial of post-operative chemotherapy for patients with stage I/II/III small bowel adenocarcinoma (JCOG1502C, J-BALLAD)
Journal of Clinical Oncology on Twitter: "Intraperitoneal and IV paclitaxel + S-1 versus cisplatin + S-1 in gastric cancer with peritoneal metastases https://t.co/DOMDsog98i #stcsm https://t.co/5Q7pI9WGMo" / Twitter
Clinical Oncology - Journal - Elsevier
Journal of Clinical Oncology :
Journals | ONS
Asia-Pacific Journal of Clinical Oncology: Vol 14, No 6